Chronic Obstructive Pulmonary Disease (COPD)

COVID-19 Patients with Food Allergies, Asthma, Eczema Had Similar Outcomes to...

News Wire ~ 3rd Party Press Release - 2020/11/16

Severity of disease did not differ between those with and those without allergies.

Teva Announces FDA Approval of First and Only Digital Inhaler with...

News Wire ~ 3rd Party Press Release - 2019/07/19

Bluetooth® Wireless Technology, Flow Sensors and Companion Mobile Application Track Inhaler Use in People with Asthma & COPD.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: Chronic Obstructive Pulmonary Disease (COPD)

COVID-19 Patients with Food Allergies, Asthma, Eczema Had Similar Outcomes to...

Teva Announces FDA Approval of First and Only Digital Inhaler with...